Ebitda تغيير تاريخ
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Baxter International USD -447M 873M 2025-12
Biogen USD 649.7M 76.5M 2026-03
Bioline Rx USD -554K 2.93M 2025-09
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Celltrion KRW 374.56B 352.67B 2025-09
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Curis USD -12.3M 231K 2023-09
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Incyte USD 414.5M 92.42M 2025-12
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
J&J USD 7.19B 2.32B 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Merck USD 6.3B 2.09B 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Novartis USD 5.3B 530M 2026-03
Organigram Holdings CAD 5.26M 884K 2025-12
Pfizer USD 6.08B 351M 2025-09
Pharma Mar EUR 44.96M 46.94M 2025-12
PTC Therapeutics USD -70.99M 91.62M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sartorius EUR 267.3M 10.1M 2026-03
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
TG Therapeutics USD 32.69M 5M 2025-09
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06